| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |